LONGMONT, Colo., July 19, 2022 /PRNewswire/ — KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of their dGH™ Cell Prep Kit for use in their dGH in-Site™…
Related Articles
News
Annual Charity Golf Outing ‘Jumping Jack to End Duchenne’ Hosts “The Final Round”
June 18, 2022
UCBN
News
Comments Off on Annual Charity Golf Outing ‘Jumping Jack to End Duchenne’ Hosts “The Final Round”
Annual Golf Tournament that Supports Parent Project Muscular Dystrophy Will Celebrate Legacy of Beloved Mother Angela Knight. WESTMINSTER, Colo., June 18, 2022 /PRNewswire/ — For 19 years, the Knight family of Westminster, Colorado has supported […]
News
Denver bioscience data software startup gets $3.7M, attention from local researchers
May 4, 2023
UCBN
News
Comments Off on Denver bioscience data software startup gets $3.7M, attention from local researchers
“I realized I was getting tired of waiting for somebody to build the software I wanted to see in the lab,” said founder and CEO Rani Powers. Click here to view original post
News
Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting
March 26, 2024
UCBN
News, Syndication
Comments Off on Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting
CUPERTINO, Calif., March 26, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of […]
